CUTEC (Cambridge University Technology & Enterprise Club) has brought together a range of high profile speakers from big tech companies to biotech start-ups, to discuss the future of biotech in healthcare.

ON Helix is One Nucleus' annual translational research conference for the Life Sciences industry. The two-day event aims at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

The Milner Therapeutics Symposium This Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute alliance partners. Non-Affiliated Companies If you […]

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning, to closing and following-up a deal – be prepared for the financial and legal pitfalls.

This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, target validation in developing advanced cellular and in vivo disease models, and the pioneering applications in therapeutic genome editing.

This meeting will be hosted by Cambridge Enterprise at the Hauser Forum on the West Cambridge site. For this meeting Professor Peter McNaughton, now at King’s College London, will update us on his research into neuropathic pain, and Professor Jim Huntington from the Cambridge Institute for Medical Research, will share some of his work and […]

ELRIG Drug Discovery 2019: Looking back to the Future 5th & 6th November, Liverpool, UK This year will include plenary introductions assessing progress so far, and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery.

The Cambridge Alliance on Medicines Safety (CAMS) is delighted to welcome Dr Chris Powell from GSK to talk about the important issue of safety studies needed to support clinical trials.

A Korean delegation of pharma, SMEs, and investment companies (including Chong Kun Dang Pharmaceuticals, SK Chemicals, Yuhan Corporation, Daewoong Pharmaceuticals Co Ltd, ShinPoong Pharm Co Ltd, Korea Investment Partners and SBI Investment) are visiting Cambridge in the hope of meeting UK biotech and pharma companies. Their aim is to identify opportunities for collaboration, investment or […]

A summit to explore the UK advantage in Cell and Gene Therapy How can joining up science and value in cell and gene therapy deliver global health impact?  The summit will explore the journey from science to patients and what value means for different people and organisations. This half day event is for scientists, investors […]

An event (with free registration) to foster the In silico Toxicology Community in the UK and beyond. Scientific contributions are as welcome as those on ongoing work, regulatory aspects, industry perspectives, databases, relevant software, journals etc. in the field.

A new monthly seminar series starting in 2020 Talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. This week's speakers are James Nathan (CITIID) & Namshik Han (Milner).

This event will include talks and a networking lunch, followed by opportunities to arrange a 1:1 meeting with representatives from the Medicines Discovery Catapult (MDC). The MDC enables academics and SMEs involved in translational biomedical research to develop their therapeutic discovery projects and associated technologies.

Public Health@Cambridge Network and Hughes Hall are hosting a one day interdisciplinary conference bringing together current Cambridge research relevant to the processes and contexts of ageing.

In this event, representatives from Johnson & Johnson Innovation will provide an overview of goals and missions, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development. Following the presentation, the Johnson & Johnson Innovation team will meet one-on-one with early-stage companies and […]

A new monthly seminar series starting in 2020. Talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. This week's speakers are Ludovic Vallier (Wellcome MRC  Cambridge Stem Cell Institute) & Pal Mander (GlaxoSmithKline)

This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, developing advanced cellular and in vivo disease models for target validation, and pioneering applications in therapeutic genome editing.

Will include presentations on a device to enhance fine motor skills, new ways to monitor blood glucose, and a spinal neurostimulation implant. Medical i-Teams investigate the best applications and routes to market for new university inventions, by interviewing relevant experts, clinicians and patient advocates.

The March meeting of the Cambridge New Therapeutics Forum (CamNTF) is now open for registration. This meeting will be hosted by the Cambridge Alliance on Medicines Safety and we are delighted to be holding this event at the newly-opened Jeffrey Cheah Biomedical Centre - home of The Milner Therapeutics Institute.